DIP Ep 604: USMLE Step 2/3 Rapid Review ...

This podcast is incredibly HY for the USMLE and COMLEX exams. In this multipart podcast series, I address herpes from an “integrative” perspective. There are so many branch points our examinee overlords can take with the herpes viruses so I aggressively go after them ... Show More

In this short podcast, I discuss the upcoming 25 Hour USMLE Step 1 Basic Science Review taking place on zoom from 6-11 pm EST from 12/1-5. The review will be incredibly clinical, focus on integrations, help you understand pathophysiology, and expose you to a large amount of the S ... Show More

In this podcast, I explain exactly what you should expect to get from all my classes. I go over each class and discuss the way they are structured, specific advantages offered by each class, and my approach to covering the material. I discuss differences between the classes and m ... Show More

<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">This week, we kick off a new series, this time focusing on follicular lymphoma! This series will build on a lot of fundamentals that we discussed in our prior series. In this first episode, we start with an ... Show More

<p class="" style="white-space:pre-wrap;">Heme Path Capstone Pt. 1 Pearls</p><p class="" style="white-space:pre-wrap;">It’s time to put all you have learned in our Heme Path series to the test! Listen in as our guest, Dr. Emily Mason, hematopathologist at Vanderbilt University Me ... Show More

Shailen Jasani introduces the podcast series and explains what you can expect. The podcasts are primarily aimed at vets and nurses in first opinion/non-referral practice as well as undergraduate and postgraduate students: Free to access and download (including via iTunes) Discuss ... Show More

<p>In Part 3 of our Heme Path series, we break down the basics of immunohistochemistry (IHC)</p><p>Episode contents: </p><p>- What is immunohistochemistry? </p><p>- What are the pros and cons? </p><p>- How do we use this clinically? </p><p>****Have some time and want to make some ... Show More

<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ... Show More

<p class="" style="white-space:pre-wrap;">Heme Path Capstone Pt. 2 Pearls</p><p class="" style="white-space:pre-wrap;">In this episode, we continue our conversation with guest, Dr. Emily Mason, hematopathologist at Vanderbilt University Medical Center (Nashville, TN), as we apply ... Show More

<p class="" style="white-space:pre-wrap;">This week, we kick off a new series focusing on diffuse large B-cell lymphoma. In this first episode, we discuss the basics that everyone needs to understand before diving into the management of this disease. </p><p class="" style="white- ... Show More

<p class="" style="white-space:pre-wrap;">In today’s episode, we discuss how to approach AML treatment for patients who are unfit for intensive therapy.</p><p class="" style="white-space:pre-wrap;">Episode contents: </p><p class="" style="white-space:pre-wrap;">- How do we assess ... Show More

<p data-rte-preserve-empty="true" style="white-space:pre-wrap;">In today’s episode, we welcome back Dr. Amar Kelkar for part 2 of our two-part discussion on allogeneic transplant. In this episode, we build on our prior discussion regarding transplant, this time focusing on transp ... Show More

<p class="" style="white-space:pre-wrap;">This week, we continue our conversation about DLBCL, this time focusing our attention on the management of early stage disease. </p><p class="" style="white-space:pre-wrap;">In this week’s episode, we delve into the management of advance ... Show More